ArticleJournal of ultrasound2025
Ultrasound-guided pericapsular nerve group (PENG) blocks are safe and effective.
Article in Journal of ultrasound, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionUltrasound-guided pericapsular nerve group (PENG) blocks are a type of regional nerve block that has gained increasing popularity for providing effective analgesia in patients with hip fractures. This retrospective case series evaluated the safety and effectiveness of Ultrasound-Guided PENG blocks using Ropivacaine 0.2% performed by emergency physicians in a single institute. Patients were enrolled between May 2019 and June 2021. The procedure was performed by emergency medicine attendings and ultrasound fellows. The patients were part of a convenience sample, with the procedure performed when an attending physician or ultrasound fellow was present in the emergency department and available to perform the procedure.
methodsWe conducted a single-center retrospective analysis of 13 PENG blocks performed by emergency medicine attendings and ultrasound fellows. This was done at our emergency department, which sees approximately 90,000 patients per year. All patients received between 1 and 3 mg/kg of Ropivacaine 0.2% with a max dosage of 120 mg (60 cc). Patient demographics, procedural details, complications, and pain outcomes were recorded.
resultsThere is a significant mean (p = 0.007) reduction in pain level of 2.9 when comparing the post-test measurements to the pre-test measurements. This was confirmed by a non-parametric approach, which also found a significant reduction in the median difference (p = 0.009). This was further explained by a non-significant Shapiro-Wilk test, which found no significant evidence of non-normality (p = 0.499). (see Table 1). Among the 13 PENG blocks performed, there were no complications. Examples of known complications of regional nerve blocks include local anesthetic systemic toxicity (Barrington and Kluger 38:289-299, 2013;El-Boghdadly and 63:330-349, 2016;) paresthesias lasting more than 5 days DISCUSSION: Our findings support the effectiveness and safety of ultrasound-guided PENG blocks performed by emergency physicians using Ropivacaine 0.2%. The high degree of pain relief and the absence of complications in our case series demonstrate that emergency physicians can perform PENG blocks with a high level of competency and safety.
conclusionThis retrospective case series, conducted between May 2019 and June 2021, demonstrates the effectiveness and safety of ultrasound-guided PENG blocks performed by emergency physicians. The high rate of pain relief and lack of complications in our patients who received the PENG block demonstrates the benefits of this technique. We suggest that additional research and randomized controlled trials will help to validate these findings and support the increased use of PENG blocks in the emergency department for the treatment of hip fractures.
Indexed as
Identifiers
40859099What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.